Please assess the completion status of the following clinical trial:

Trial Title: EXALT: EXercise Attenuates Liver Tumors Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults age \>=18 or \<70 years~* Liver transplant candidates (under evaluation or listed for transplant with HCC)~* Hepatocellular Carcinoma diagnosis (HCC)~* Complete response to LRT~Exclusion Criteria:~* Active cardiac symptoms~* BMI \<18 or \>45 kg/m2(16)~* CPT Class B or C liver disease~* ECOG \>2~* Hepatic decompensation~* Institutionalized/prisoner~* Pregnancy~* Severe medical comorbidities/psychiatric illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Study Arms:
- Exercise intervention (Type: EXPERIMENTAL): The exercise program will be similar to the Exercise in All ChemoTherapy (ENACT) study which combines in-person and home-based strength training and aerobic exercise five days a week.
- Standard of Care (Type: NO_INTERVENTION): Subjects are instructed to maintain their current activity level.

Based on this trial design, predict the completion outcome and termination type (if applicable).